Congestion And Cough Solution
NDC Package 69842-756-88

View Billable Units, 11-Digit Conversion Format, and RxNorm mappings

Package Information

Congestion And Cough (dextromethorphan hbr, guaifenesin, phenylephrine hcl) solution is mL = milliliter; FL OZ = fluid ounceuse only enclosed dosing cup designed for use with this product. This formulation utilizes a solution delivery system. Marketed by Cvs Pharmacy, this product is identified by NDC 69842-756 and is authorized under FDA application M012.

Identification & Billing

NDC Package Code
69842-756-88
Package Description
1 BOTTLE, PLASTIC in 1 CARTON / 201 mL in 1 BOTTLE, PLASTIC
Product Code
11-Digit Billing Format
69842075688
RxNorm Crosswalk
  • RxCUI: 1043543 - dextromethorphan HBr 5 MG / guaiFENesin 100 MG / phenylephrine HCl 2.5 MG in 5 mL Oral Solution
  • RxCUI: 1043543 - dextromethorphan hydrobromide 1 MG/ML / guaifenesin 20 MG/ML / phenylephrine hydrochloride 0.5 MG/ML Oral Solution
  • RxCUI: 1043543 - dextromethorphan HBr 20 MG / guaifenesin 400 MG / phenylephrine HCl 10 MG per 20 ML Oral Solution
  • RxCUI: 1043543 - dextromethorphan HBr 5 MG / guaifenesin 100 MG / phenylephrine HCl 2.5 MG per 5 ML Oral Solution

Clinical Specifications

Proprietary Name
Congestion And Cough Childrens
Non-Proprietary Name
Dextromethorphan Hbr, Guaifenesin, Phenylephrine Hcl
Substance Name
Dextromethorphan Hydrobromide; Guaifenesin; Phenylephrine Hydrochloride
Dosage Form
Solution - A clear, homogeneous liquid1 dosage form that contains one or more chemical substances dissolved in a solvent or mixture of mutually miscible solvents.
Administration Route
Oral - Administration to or by way of the mouth.
Usage Information
ML = milliliter; FL OZ = fluid ounceuse only enclosed dosing cup designed for use with this product. Do notuse any other dosing device.dose as follows or as directed by a doctordo not take more than 6 doses in any 24-hour periodAgeDosechildren 6 years to under 12 years10 mL every 4 hourschildren 4 years to under 6 years5 mL every 4 hourschildren under 4 yearsdo not use

Regulatory & Marketing

Labeler Name
Cvs Pharmacy
Product Type
Human Otc Drug
FDA Application #
M012
Marketing Category
OTC MONOGRAPH DRUG -
Start Marketing Date
07-01-2018
Listing Expiration
12-31-2027
Exclude Flag
N
Sample Package
No

Hierarchy Structure

Code Lineage

The NDC Directory contains ONLY information on final marketed drugs submitted to FDA electronically by labelers. A labeler might be a manufacturer, re-packager or re-labeler. The product information included in the NDC directory does not indicate that FDA has verified the information provided by the product labeler. Assigned NDC numbers are not in any way an indication of FDA approval of the product.

* Please review the full disclaimer at the bottom of this page.

Frequently Asked Questions

What is the distribution configuration for this product package?

The code 69842-756-88 identifies a specific commercial package of 1 bottle, plastic in 1 carton / 201 ml in 1 bottle, plastic of Congestion And Cough Childrens, a human over the counter drug labeled by Cvs Pharmacy. This solution is formulated for oral use and contains dextromethorphan hydrobromide; guaifenesin; phenylephrine hydrochloride as the active substance.

Is this product currently listed with the FDA?

Yes, this product is active and verified within the NDC Directory. It was introduced to the market by Cvs Pharmacy on July 01, 2018. The current certification is valid through December 31, 2027.

How is this Cvs Pharmacy product billed for insurance claims?

For medical billing and reimbursement, this package follows the 11-digit CMS format: 69842075688. The table below illustrates the segment conversion from the 10-digit labeler code to the 11-digit provider format.

11-Digit Code Conversion

Billing payers usually require a 5-4-2 segment configuration. Below is the conversion from the 10-digit package format to the 11-digit billing format:

10-Digit Format (5-3-2)
69842-756-88
11-Digit CMS (5-4-2)
69842-0756-88

Note: The zero is added to the Product segment to maintain the 5-4-2 structure.